[144] Enova International, Inc. SEC Filing

Rhea-AI Filing Summary

Enova International, Inc. (ENVA) Form 144 shows a proposed sale of 10,000 common shares through Merrill Lynch (Chicago) with an aggregate market value of $1,210,000.00 and an approximate sale date of 08/29/2025 on the NYSE. The securities were acquired on 02/12/2019 by stock option from Enova International. Recent reported sales by the same account (David Fisher) in the past three months total 32,000 shares with gross proceeds of $3,090,958.57 across four transactions dated 06/20/2025, 07/14/2025, 08/26/2025 and 08/28/2025. Certain filer and issuer contact fields in the filing appear blank or not provided in the extract.

Positive

• Full transaction details provided for the proposed sale including broker, quantity, market value, exchange, and acquisition method
• Recent prior sales disclosed showing transparency about insider dispositions (32,000 shares, ~$3.09M proceeds)

Negative

• Some issuer and filer contact fields are blank or not provided in the supplied extract
• No disclosure of a 10b5-1 plan adoption date or trading-plan details in the provided content

Insights

Securities Analyst

TL;DR Routine insider sale filing: 10,000 shares proposed for sale, recent activity shows material insider liquidity.

The filing documents a Rule 144 notice for 10,000 common shares valued at $1.21 million to be sold via Merrill Lynch on the NYSE, originating from stock options granted on 02/12/2019. The seller previously sold 32,000 shares in the last three months, generating roughly $3.09 million in gross proceeds. This pattern indicates ongoing disposition of previously granted equity rather than an issuance or corporate action. From an investor-impact perspective, this is typically neutral but notable for monitoring insider selling cadence and potential supply into the market.

Compliance/Risk Analyst

TL;DR Filing appears procedurally complete for a Rule 144 notice but contains omitted contact fields in the provided extract.

The Form 144 lists required transaction details: class, broker, quantity, market value, acquisition date, and recent sales. It affirms the signer represents no undisclosed material adverse information. However, several issuer and filer contact fields are blank in the provided content, which may reflect an incomplete extract rather than a deficiency in the actual filing. For compliance review, documentation of the trading plan or 10b5-1 adoption date (if applicable) would be relevant but is not present in the text supplied.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 110 N Wacker Dr Ste 1900 Chicago IL 60606	10000	1210000.00	25012613	08/29/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/12/2019	Stock Options	Enova International			10000	02/12/2019	Stock Option

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Fisher 175 West Jackson Blvd, Suite 600 Chicago IL 60604	Common	06/20/2025	2000	196762.87
David Fisher 175 West Jackson Blvd Suite 600 Chicago IL 60604	Common	07/14/2025	5000	575951.66
David Fisher 175 West Jackson Blvd Suite 600 Chicago IL 60604	Common	08/26/2025	5000	588801.44
David Fisher 175 West Jackson Blvd Suite 600 Chicago IL 60604	Common	08/28/2025	15000	1826442.60

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Form 144 for ENVA show about the proposed sale?

The filing lists a proposed sale of 10,000 ENVA common shares via Merrill Lynch with an aggregate market value of $1,210,000.00 and an approximate sale date of 08/29/2025 on the NYSE.

When were the shares being sold originally acquired?

The 10,000 shares were acquired on 02/12/2019 via stock options from Enova International.

How much insider selling by the same account occurred in the past three months?

The filing discloses four sales by David Fisher totaling 32,000 shares with combined gross proceeds of $3,090,958.57 on dates 06/20/2025, 07/14/2025, 08/26/2025 and 08/28/2025.

Which broker is handling the proposed sale?

The proposed sale is to be handled by Merrill Lynch, 110 N Wacker Dr, Ste 1900, Chicago, IL 60606.

Does the Form 144 indicate any undisclosed material information?

The signer represents by signature that they do not know any material adverse information not publicly disclosed; no undisclosed material information is stated in the filing extract.